Psoriasis is a chronic immune-mediated inflammatory disease that affects millions of people worldwide. It mainly affects the skin, causing red, thick, scaly patches that can sometimes be itchy, sore, or uncomfortable. Over the past decade, treatments for psoriasis have improved considerably, helping many sufferers to manage their symptoms more effectively. However, researchers are still working to better understand exactly what causes psoriasis and how to develop additional therapies with greater effectiveness.
One of the most valuable ways that scientists study psoriasis is by examining small samples of human skin tissue (biopsies) donated from people who live with the condition. By studying real human tissue, scientists can gain insights into how the disease develops, how it responds to treatments, and how new drugs can be designed to target the root causes of inflammation.
Psoriasis is caused by problems with the immune system that lead to inflammation in the skin. In healthy skin, new skin cells grow slowly and replace old cells over several weeks. In people with psoriasis, this process happens much faster. Skin cells build up too quickly, forming thick, scaly patches called plaques.
Scientists can study psoriasis using laboratory models and cell culture methods, but these methods cannot fully replicate the complexity of real human skin. Skin contains many different types of cells that interact with each other in complex ways.
By studying skin samples from people with psoriasis, researchers can observe things such as:
How Immune cells behave in inflamed skin
These insights are essential for understanding the biological processes that drive psoriasis and for identifying potential therapeutic targets.
Human tissue studies provide a disease-relevant model that closely reflects what happens in patients, offering critical insights into psoriasis that simpler experimental systems cannot provide. By examining skin tissue from individuals with the condition, researchers can:
Because psoriasis involves complex interactions between the immune system, skin cells, and inflammatory mediators, these studies are essential for supporting drug discovery and development. Testing potential therapies in human tissue models allows scientists to assess their ability to reduce inflammation or normalize skin cell behavior, generating data-rich insights that inform clinical trial decisions and accelerate the development of more effective treatments.
Many advances in psoriasis research are only possible because people living with the disease chose to participate in research studies. Volunteers may provide the biological material – skin biopsies – that researchers need to study the disease and develop new therapeutic approaches.
These volunteer donations are key and help scientists:
Every tissue sample donated contributes valuable information to help bring new medicines to the market and improve the lives of patients living with psoriasis.
As researchers continue to explore new strategies for treating inflammatory diseases, human tissue studies remain a critical component of psoriasis research. By studying real patient tissue, scientists can gain deeper insights into disease biology and develop therapies that are more targeted, effective, and relevant to patients.
Ultimately, progress in psoriasis research depends on the key collaboration between scientists and volunteers who together contribute to advancing medical discovery.